At this time, I would like to welcome everyone to the Karyopharm Therapeutics fourth quarter and full year 2024 financial results conference call. There will be a question-and-answer session to follow ...

The chemical creates trihalomethanes (THMs) that increase the risk of bladder cancer by 33 percent and colorectal cancer by ...

Around 4,500 women in the UK will be eligible for treatment ... as Myfembree for uterine fibroids, where the GnRH antagonist is also sold on its own as Orgovyx for prostate cancer.

Researchers sought to assess barriers to and facilitators of first-line treatment intensification by physician practice setting and intensification frequency in mCSPC.

Patients with localized muscle-invasive bladder cancer (MIBC) who received radiation plus the immune checkpoint inhibitors (ICIs) durvalumab (Imfinzi) and tremelimumab (Imjudo) had durable responses ...

Market OverviewThe Global Hormone Replacement Therapy Market is valued at USD 22.6 Billion in 2023 and is projected to reach ...

Getting your period twice a month? It could be due to hormonal imbalances, stress, or health issues like PCOS or thyroid ...

More than 67,000 Americans will be diagnosed with pancreatic cancer this year. Learn more about the disease and how PanCAN can help.